Jennifer Lachey
2020
In 2020, Jennifer Lachey earned a total compensation of $3.5M as Chief Scientific Officer at Keros Therapeutics, a 755% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $154,200 |
---|---|
Option Awards | $3,017,362 |
Salary | $370,196 |
Other | $521 |
Total | $3,542,278 |
Lachey received $3M in option awards, accounting for 85% of the total pay in 2020.
Lachey also received $154.2K in non-equity incentive plan, $370.2K in salary and $521 in other compensation.
Rankings
In 2020, Jennifer Lachey's compensation ranked 3,269th out of 13,090 executives tracked by ExecPay. In other words, Lachey earned more than 75.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,269 out of 13,090 | 75th |
Division Manufacturing | 1,267 out of 5,624 | 78th |
Major group Chemicals And Allied Products | 477 out of 2,257 | 79th |
Industry group Drugs | 413 out of 1,957 | 79th |
Industry Pharmaceutical Preparations | 307 out of 1,462 | 79th |
Source: SEC filing on April 19, 2021.
Lachey's colleagues
We found two more compensation records of executives who worked with Jennifer Lachey at Keros Therapeutics in 2020.